JPY 303.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.23 Billion JPY | 52.56% |
2022 | 617.61 Million JPY | 68.8% |
2021 | 569.32 Million JPY | 1366.37% |
2020 | -475.14 Million JPY | -98.45% |
2019 | 1.06 Billion JPY | -9.74% |
2018 | 2.57 Billion JPY | -4.81% |
2017 | 2.33 Billion JPY | -17.39% |
2016 | 1.42 Billion JPY | 24.52% |
2015 | 2.92 Billion JPY | -34.64% |
2014 | 3.51 Billion JPY | -15.24% |
2013 | 4.88 Billion JPY | 9.26% |
2012 | 4 Billion JPY | -9.79% |
2011 | 4.71 Billion JPY | 14.4% |
2010 | 3.93 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 235.25 Million JPY | 35.93% |
2023 Q3 | 337.01 Million JPY | -1.78% |
2023 Q4 | 268.29 Million JPY | -20.39% |
2023 FY | - JPY | 52.56% |
2023 Q1 | 245.81 Million JPY | -2.14% |
2023 Q2 | 343.13 Million JPY | 39.59% |
2022 FY | - JPY | 68.8% |
2022 Q3 | 19.67 Million JPY | 110.35% |
2022 Q4 | 251.18 Million JPY | 1176.74% |
2022 Q1 | 54.61 Million JPY | 112.5% |
2022 Q2 | -190.15 Million JPY | -448.16% |
2021 Q2 | 12.27 Million JPY | 119.23% |
2021 Q3 | 329.37 Million JPY | 2584.38% |
2021 Q4 | -437.1 Million JPY | -232.71% |
2021 FY | - JPY | 1366.37% |
2021 Q1 | -63.81 Million JPY | 69.1% |
2020 Q2 | -79.02 Million JPY | 69.03% |
2020 Q1 | -255.2 Million JPY | -247.23% |
2020 Q3 | -80.11 Million JPY | -1.37% |
2020 Q4 | -206.53 Million JPY | -157.8% |
2020 FY | - JPY | -98.45% |
2019 Q4 | -73.49 Million JPY | -130.75% |
2019 Q1 | 858.38 Million JPY | 268.2% |
2019 FY | - JPY | -9.74% |
2019 Q2 | 296.17 Million JPY | -65.5% |
2019 Q3 | 239 Million JPY | -19.3% |
2018 Q1 | 231.4 Million JPY | -11.75% |
2018 FY | - JPY | -4.81% |
2018 Q3 | 510.54 Million JPY | 22.37% |
2018 Q2 | 417.21 Million JPY | 80.29% |
2018 Q4 | 233.13 Million JPY | -54.34% |
2017 Q4 | 262.23 Million JPY | 327.11% |
2017 FY | - JPY | -17.39% |
2017 Q2 | 448.1 Million JPY | 62.69% |
2017 Q1 | 275.43 Million JPY | -70.45% |
2017 Q3 | -115.46 Million JPY | -125.77% |
2016 FY | - JPY | 24.52% |
2016 Q4 | 932.05 Million JPY | 698.13% |
2016 Q3 | -155.82 Million JPY | -146.37% |
2016 Q2 | 336.06 Million JPY | 612.06% |
2016 Q1 | 47.19 Million JPY | -92.96% |
2015 Q3 | -358 Million JPY | -149.59% |
2015 Q4 | 670.75 Million JPY | 287.36% |
2015 FY | - JPY | -34.64% |
2015 Q1 | 62.87 Million JPY | -92.74% |
2015 Q2 | 721.98 Million JPY | 1048.35% |
2014 FY | - JPY | -15.24% |
2014 Q4 | 866.48 Million JPY | 2124.32% |
2014 Q3 | 38.95 Million JPY | -96.18% |
2014 Q1 | 406.24 Million JPY | -15.07% |
2014 Q2 | 1.01 Billion JPY | 151.04% |
2013 Q3 | 859.89 Million JPY | -17.12% |
2013 Q2 | 1.03 Billion JPY | 35.91% |
2013 Q1 | 763.41 Million JPY | 227.58% |
2013 FY | - JPY | 9.26% |
2013 Q4 | 478.3 Million JPY | -44.38% |
2012 Q3 | 994.56 Million JPY | 23.97% |
2012 FY | - JPY | -9.79% |
2012 Q4 | 233.04 Million JPY | -76.57% |
2012 Q1 | 670.92 Million JPY | 45.44% |
2012 Q2 | 802.26 Million JPY | 19.58% |
2011 Q4 | 461.31 Million JPY | 0.0% |
2011 FY | - JPY | 14.4% |
2010 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
AS PARTNERS CO LTD | 1.07 Billion JPY | -14.343% |
I'rom Group Co., Ltd. | 2.27 Billion JPY | 45.632% |
Saint-Care Holding Corporation | 4.04 Billion JPY | 69.465% |
Artra Group Corporation | 228.12 Million JPY | -441.244% |
Charm Care Corporation | 6.31 Billion JPY | 80.433% |
Elan Corporation | 3.85 Billion JPY | 67.956% |
Solasto Corporation | 8.85 Billion JPY | 86.058% |
teno. Holdings Company Limited | 616 Million JPY | -100.437% |
Japan Hospice Holdings Inc. | 1.69 Billion JPY | 27.176% |
baby calendar Inc. | 11.62 Million JPY | -10521.912% |
Advantage Risk Management Co., Ltd. | 1.41 Billion JPY | 12.575% |